Company / Current Assets
Ginkgo Bioworks Holdings, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$471.8M
FY2025
5-year range
$471.8M / $1.7B
FY2021-FY2025
Trend
-21.7%
vs FY2024
Sector context
#122 of 215
Health Care
What the data says
At $472M, Ginkgo Bioworks Holdings, Inc.'s current assets ranks #122 of 215 in the Health Care sector. Current Assets has declined for 4 consecutive years, from $1.7B in FY2021 to $472M in FY2025.
Based on SEC 10-K filings.
$472M in FY2025 with a 5-year CAGR of +2.0%.
Declined from $1.0B to $472M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -31.2%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
#122 of 215 in Health CareTop 57% of 215This company $471.8M Sector average $2.5B
▼
-81.4% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of +2.0%, indicating consistent growth.
- In FY2025, current assets decreased 21.7% year-over-year.
- Ranks #122 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $471.8M | -21.7% |
| FY2024 | $602.7M | -39.8% |
| FY2023 | $1.0B | -30.9% |
| FY2022 | $1.5B | -15.8% |
| FY2021 | $1.7B | +304.0% |
| FY2020 | $426.5M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026